Sputum-guided care to help manage COPD flare-ups
Part of Lungs & breathing clinical trials.
This trial tests a COPD care plan guided by what’s found in your mucus (sputum), along with comprehensive case management. It aims to reduce COPD flare-ups and improve day-to-day health for people with a history of frequent exacerbations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least 2 COPD flare-ups in the past 12 months
- A breathing test or scan shows COPD (FEV1/FVC below 0.7, or emphysema seen on imaging)
- You have a smoking history of more than 10 pack-years
- You do not have severe mental illness that is not controlled by medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a coordinated (multidisciplinary) care program for people with severe COPD who were recently hospitalized for worsening breathing symptoms. It may help reduce future flare-ups and improve day-to-day breathing by coordinating multiple types of care in a COPD center.
This trial tests whether people being checked for possible lung cancer can also get improved care for a breathing condition called COPD (chronic obstructive pulmonary disease). It focuses on patients whose lung function tests show airflow problems.
This trial tests if people with COPD can use a home monitoring system after a flare-up to help doctors track their recovery. It aims to reduce hospital visits and improve care.
This study looks at the risk of heart problems in people hospitalized for a sudden worsening of COPD. It aims to understand how COPD flare-ups affect the heart.
This trial compares customized durations of antibiotics to standard durations for treating acute worsening of COPD. It aims to see if stopping antibiotics early when symptoms improve is as effective as the usual fixed course.
This study uses analysis of mucus (sputum) to guide treatment with the goal of reducing long-lasting cough in adults with interstitial lung disease (ILD). You may be asked to provide sputum samples and may receive treatment decisions based on those results.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.